type here...

CATEGORIES

Medication

LATEST

1234Page 3 of 4

TRENDING

EDITORS CHOICE

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

Does Botox Drop Anxiety?

Michael Hunter, MD -
WITH DISEASE SPREAD AND DEATHS, large outbreaks of Covid-19 infection are associated with fear and grief. I don't know about you, but the limits on...

The MDMA-Assisted Therapy for PTSD Study. What You’ll Get Wrong

James Coyne -
Readers, including even experts, are falling for a hard sell job by venture capitalists who launder their funding of the study through a nonprofit foundation and seek not legalization

As Opioids Mixed With Animal Tranquilizers Arrive in Kensington, So Do Alarming Health Challenges

Medika Life -
The neighborhood’s afflictions date to the early 1970s, when industry left and the drug trade took hold. With each new wave of drugs, the situation grows grimmer. Now, with the arrival of xylazine, a veterinary tranquilizer, new complications are burdening an already overtaxed system.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories